Zhejiang Huahai Biological Pharmaceutical Co., Ltd.
Evaluation of the Auditor's Performance in 2025 and Report on the Audit Committee's Fulfillment of Supervisory Duties
In accordance with the "Company Law of the People's Republic of China," "Securities Law of the People's Republic of China," "Corporate Governance Guidelines for Listed Companies," "Measures for the Selection of Auditors for State-owned Enterprises and Listed Companies," "Shenzhen Stock Exchange Listed Company Self-regulatory Supervision Guide No. 2 - Norms for Operation of GEM Listed Companies," and the "Articles of Association," Zhejiang Huahai Biological Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") Audit Committee, adhering to the principle of diligence and conscientiousness, has diligently performed its duties. The evaluation of the auditor's performance in 2025 and the fulfillment of supervisory duties by the Audit Committee are hereby reported as follows:
I. Basic Information of the 2025 Annual Audit Auditor
(I) Basic Information of the Accounting Firm
Institution Name: Beijing Dehao International Certified Public Accountants (Special General Partnership) Date of Establishment: December 8, 2008 Organizational Form: Special General Partnership Registered Address: Floor 5, Room 519A, 31 Fuchengmenwai Street, Xicheng District, Beijing Chief Partner: Zhao Huanqi As of December 31, 2025, Beijing Dehao International Certified Public Accountants (Special General Partnership) had 72 partners, 296 certified public accountants, and 165 certified public accountants who had signed audit reports for securities service businesses.
(II) Procedures for Appointing the Accounting Firm